Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility

Publication Date: February 3, 2022
Last Updated: March 14, 2022

Analgesia

Having trouble viewing table?
Recommendations
Strength Quality
We suggest that, in critically ill pediatric patients 6 yr old and older who are capable of communicating, pain assessment via self-report be routinely performed using the Visual Analog Scale, Numeric Rating Scale, Oucher Scale, or Wong-Baker Faces pain scale. Conditional Low
We recommend the use of either the Faces, Legs, Activity, Cry, and Consolability or COMFORT-B scales for assessing pain in non-communicative critically ill pediatric patients. Strong Moderate
We recommend the use of observational pain assessment tools rather than vital signs alone for assessment of postoperative pain in critically ill pediatric patients. Strong Moderate
We suggest the use of observational pain assessment tools rather than vital signs alone for assessment of procedure-related pain in critically ill pediatric patients. Conditional Low
We recommend that IV opioids be used as the primary analgesic for treating moderate to severe pain in critically ill pediatric patients. Strong Moderate
We recommend the addition of an adjunct NSAID (IV or oral) to improve early postoperative analgesia in critically ill pediatric patients. Strong Moderate
We suggest the addition of an adjunct NSAID agent (IV or oral) to decrease opioid requirements in the immediate postoperative period in critically ill pediatric patients. Conditional Low
We suggest the addition of adjunct acetaminophen (IV or oral) to improve early postoperative analgesia in critically ill pediatric patients. Conditional Low
We suggest the addition of adjunct acetaminophen (IV or oral) to decrease opioid requirements in the immediate postoperative period in critically ill pediatric patients. Conditional Low
We recommend that music therapy be offered to augment analgesia in critically ill postoperative pediatric patients. Strong Moderate
We recommend that nonnutritive sucking with oral sucrose be offered to neonates and young infants prior to performing invasive procedures. Strong High

Sedation

Having trouble viewing table?
Recommendations
Strength Quality
We recommend the use of the COMFORT-B Scale or the State Behavioral Scale, to assess level of sedation in mechanically ventilated pediatric patients. Strong Moderate
We suggest the use of the Richmond Agitation-Sedation Scale to assess level of sedation in mechanically ventilated pediatric patients. Conditional Low
We suggest that all pediatric patients requiring MV are assigned a target depth of sedation using a validated sedation assessment tool at least once daily. Conditional Low
We suggest the use of protocolized sedation in all critically ill pediatric patients requiring sedation and/or analgesia during MV. Conditional Low
The addition of daily sedation interruption to sedation protocolization is not suggested due to lack of improvement in outcomes. Conditional Low
During the periextubation period when sedation is typically lightened, we suggest the following bundle strategies to decrease risk of inadvertent device removal:
  a) Assign a target depth of sedation at increasing frequency to adapt to changes inpatient clinical status and communicate strategies to reach titration goal.
  b) Consider a sedation weaning protocol.
  c) Consider unit standards for securement of endotracheal tubes and safety plan.
  d) Restrict nursing workload to facilitate frequent patient monitoring, decrease sedation requirements, and risk of self-harm.
Conditional Low
We suggest the use of alpha2-agonists as the primary sedative class in critically ill pediatric patients requiring MV. Conditional Low
We recommend that dexmedetomidine be considered as a primary agent for sedation in critically ill pediatric post-operative cardiac surgical patients with expected early extubation. Strong Moderate
We suggest the use of dexmedetomidine for sedation in critically ill pediatric postoperative cardiac surgical patients to decrease the risk of tachyarrhythmias. Conditional Low
We suggest that continuous propofol sedation at doses less than 4 mg/kg/hr (67 µg/kg/min) and administered for less than 48 hr may be a safe sedation alternative to minimize the risk of propofol-related infusion syndrome development. Conditional Low
Short term (< 48 hr) continuous propofol sedation may be a useful adjunct during the periextubation period to facilitate weaning of other analgosedative agents prior to extubation. Good practice
We suggest consideration of adjunct sedation with ketamine in patients who are not otherwise at an optimal sedation depth. Conditional Low
During the periextubation period when sedation is typically lightened, we suggest the following bundle strategies to decrease risk of inadvertent device removal:
   a) Assign a target depth of sedation at increasing frequency to adapt to changes inpatient clinical status and communicate strategies to reach titration goal.
   c) Consider a sedation weaning protocol.
   e) Consider unit standards for securement of endotracheal tubes and safety plan.
   d) Restrict nursing workload to facilitate frequent patient monitoring, decrease sedation requirements, and risk of self-harm.
Conditional Low

Neuromuscular blockade

Having trouble viewing table?
Recommendations
Strength Quality
We suggest that train-of-four monitoring be used in concert with clinical assessment to determine depth of neuromuscular blockade. Conditional Low
We suggest using the lowest dose of NMBAs required to achieve desired clinical effects and manage undesired breakthrough movement. Conditional Low
Electroencephalogram-based monitoring may be a useful adjunct for assessment of sedation depth in critically ill pediatric patients receiving NMBAs. Good practice
We suggest that sedation and analgesia should be adequate to prevent awareness prior to and throughout NMBA use. Conditional Low
We recommend routine use of passive eyelid closure and eye lubrication for the prevention of corneal abrasions in critically ill pediatric patients receiving NMBAs. Strong Moderate

ICU delirium

Having trouble viewing table?
Recommendations
Strength Quality
We recommend use of the preschool and pediatric Confusion Assessment Methods for the ICU or the Cornell Assessment for Pediatric Delirium as the most valid and reliable delirium monitoring tools in critically ill pediatric patients. Strong High
We recommend routine screening for ICU delirium using a validated tool in critically ill pediatric patients upon admission through ICU discharge or transfer. Strong High
Given low patient risk, and possible patient benefit to reduce the incidence and/or decrease duration or severity of delirium we suggest the following non-pharmacologic strategies: optimization of sleep hygiene, use of interdisciplinary rounds, family engagement on rounds, and family involvement with direct-patient care. Conditional Low
We suggest performing EM, when feasible, to reduce the development of delirium. Conditional Low
We recommend minimizing benzodiazepine-based sedation when feasible in critically ill pediatric patients to decrease incidence and/or duration or severity of delirium. Strong Moderate
We suggest strategies to minimize overall sedation exposure whenever feasible to reduce coma and the incidence and/or severity of delirium in critically ill children. Conditional Low
We do not suggest routine use of haloperidol or atypical antipsychotics for the prevention of or decrease in duration of delirium in critically ill pediatric patients. Conditional Low
We suggest that in critically ill pediatric patients with refractory delirium, haloperidol or atypical antipsychotics be considered for the management of severe delirium manifestations, with consideration of possible adverse drug effects. Conditional Moderate
We recommend a baseline electrocardiogram followed by routine electrolyte and QTc interval monitoring for patients receiving haloperidol or atypical antipsychotics. Strong Moderate

IWS

Having trouble viewing table?
Recommendations
Strength Quality
We recommend use of either the Withdrawal Assessment Tool-1or Sophia Observation Scale for the assessment of IWS due to opioid or benzodiazepine withdrawal in critically ill pediatric patients. Strong Moderate
We suggest routine IWS screening after a shorter duration (3–5 d) when higher opioid or benzodiazepine doses are used. Conditional Moderate
Until a validated screening tool is developed, monitoring for IWS from alpha2-agonists should be performed using a combination of associated symptoms (unexplained hypertension or tachycardia) with adjunct use of a validated benzodiazepine or opioid screening tool. Good practice
We suggest that opioid related IWS be treated with opioid replacement therapy to attenuate symptoms, irrespective of preceding dose and /or duration or opioid exposure. Conditional Low
Benzodiazepine-related IWS should be treated with benzodiazepine replacement therapy to attenuate symptoms, irrespective of preceding dose and/or duration of benzodiazepine exposure. Good practice
Alpha2-agonist–related IWS should be treated with IV and/or or enteral alpha2-agonist replacement therapy to attenuate symptoms, irrespective of preceding dose and/or duration of alpha2-agonist exposure. Good practice
We suggest use of a standardized protocol for sedation/analgesia weaning to decrease duration of sedation taper and attenuate emergence of IWS. Conditional Low

Optimizing environment

Having trouble viewing table?
Recommendations
Strength Quality
We suggest facilitation of parental or caregiver presence in the PICU during routine care and interventional procedures to a) provide comfort to the child, b) decrease parental levels of stress and anxiety and c) increase level of satisfaction of care. Conditional Low
We suggest offering patients the use of noise reducing devices such as ear plugs or headphones to reduce the impact of non-modifiable ambient noise (conditional, low-level evidence). Conditional Low
We suggest that PICU teams make environmental and/or behavioral changes to reduce excessive noise and therefore improve sleep hygiene and comfort, in critically ill pediatric patients. Conditional Low
We suggest performing EM to minimize the effects of immobility in critically ill pediatric patients. Conditional Low
We suggest the use of a standardized EM protocol that outlines readiness criteria, contraindications, developmentally appropriate mobility activities and goals, and safety thresholds guided by the multidisciplinary team and family decision-making. Conditional Low

Recommendation Grading

Overview

Title

Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility

Authoring Organization

Society of Critical Care Medicine

Publication Month/Year

February 3, 2022

Last Updated Month/Year

April 1, 2024

Supplemental Implementation Tools

Document Type

Guideline

Country of Publication

US

Inclusion Criteria

Male, Female, Adolescent, Child, Infant

Health Care Settings

Emergency care, Hospital

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Management, Prevention

Diseases/Conditions (MeSH)

D019148 - Neuromuscular Blockade, D003693 - Delirium

Keywords

delirium, pediatrics, Agitation, neuromuscular blockade, ICU, delirium prevention

Source Citation

Smith HAB, Besunder JB, Betters KA, Johnson PN, Srinivasan V, Stormorken A, Farrington E, Golianu B, Godshall AJ, Acinelli L, Almgren C, Bailey CH, Boyd JM, Cisco MJ, Damian M, deAlmeida ML, Fehr J, Fenton KE, Gilliland F, Grant MJC, Howell J, Ruggles CA, Simone S, Su F, Sullivan JE, Tegtmeyer K, Traube C, Williams S, Berkenbosch JW. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility. Pediatr Crit Care Med. 2022 Feb 1;23(2):e74-e110. doi: 10.1097/PCC.0000000000002873. PMID: 35119438.

Supplemental Methodology Resources

Data Supplement

Methodology

Number of Source Documents
348
Literature Search Start Date
December 31, 1989
Literature Search End Date
December 31, 2019